Omada Health, Inc. Operating Cash Flow
Omada Health, Inc. (OMDA) reported Operating Cash Flow of -$7.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- Omada Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $4.01M, a 40.20% increase year-over-year.
- Omada Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.83M.
- Omada Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $21.38M.
- Omada Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $10.13M, a 859.56% increase year-over-year.
- Omada Health, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $18.25M.
- Omada Health, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$34.18M.
- Omada Health, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$49.74M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$7.83M 10-Q · filed 2026-08-07 | $13.55M derived: sum of 3 quarters · filed 2026-08-07 | $23.68M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$11.83M 10-Q · filed 2026-05-08 | $9.54M derived: sum of 2 quarters · filed 2026-05-08 | $19.68M derived: sum of 3 quarters · filed 2026-05-08 | $22.54M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $21.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $31.51M derived: sum of 2 quarters · filed 2026-03-06 | $34.37M derived: sum of 3 quarters · filed 2026-08-07 | $18.25M 10-K · filed 2026-03-06 |
| 2025-09-30 | $10.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $12.99M derived: sum of 2 quarters · filed 2026-08-07 | -$3.13M 10-Q · filed 2025-11-07 | -$9.61M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$13.26M 10-Q · filed 2026-08-07 | -$19.75M derived: sum of 3 quarters · filed 2026-08-07 | -$18.69M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$16.12M 10-Q · filed 2026-05-08 | -$22.61M derived: sum of 2 quarters · filed 2026-05-08 | -$21.55M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$5.43M derived: sum of 2 quarters · filed 2026-03-06 | -$34.18M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$27.69M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | -$28.75M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | -$49.74M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |